Table 2.
Baseline characteristics | Full cohort, n (%) |
---|---|
Race/ethnicity | |
Black, non-Hispanic | 88 (38.9%) |
White, non-Hispanic | 71 (31.4%) |
Hispanic or Latinx | 24 (10.6%) |
Other | 3 (1.4%) |
Unknown | 40 (17.7%) |
Psychiatric comorbidities* + | |
Depression | 86 (38.1%) |
Anxiety | 78 (34.5%) |
Post Traumatic Stress Disorder | 42 (18.6%) |
Bipolar disorder | 37 (16.4%) |
Schizophrenia/schizoaffective disorder | 26 (11.5%) |
Brain injury | 13 (5.8%) |
Active substance use at time of admission* + | |
Alcohol | 64 (28.3%) |
Opioids | 43 (19.0%) |
Cocaine/crack | 43 (19.0%) |
Methamphetamines | 4 (1.8%) |
Benzodiazepines (not prescribed) | 3 (1.3%) |
*Not mutually exclusive
+Reported in electronic health record or medical provider’s assessment